PBM

Propel Bio Management Portfolio holdings

AUM $82.4M
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
-$17.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
32
New
Increased
Reduced
Closed

Top Buys

1
+$25.8M
2
+$5.29M
3
+$3.1M
4
ARDX icon
Ardelyx
ARDX
+$2.45M
5
APLT icon
Applied Therapeutics
APLT
+$2.13M

Top Sells

1
+$28M
2
+$4.47M
3
+$2.07M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
+$1.76M
5
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$1.63M

Sector Composition

1 Healthcare 79.89%
2 Energy 16.75%
3 Technology 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$30.7M 19.89%
6,567,858
+455,952
2
$25.8M 16.75%
+1,372,360
3
$12.2M 7.92%
2,087,139
4
$12.1M 7.82%
43,032
5
$11.5M 7.48%
2,453,092
6
$8.96M 5.81%
869,927
7
$7.69M 4.99%
327,752
8
$7.29M 4.73%
178,500
9
$6.85M 4.44%
924,583
+330,409
10
$5.29M 3.43%
+1,248,044
11
$4.65M 3.02%
750,000
12
$3.96M 2.57%
1,492,792
13
$3.33M 2.16%
365,781
+75,000
14
$3.1M 2.01%
+42,494
15
$2.68M 1.74%
130,000
16
$1.85M 1.2%
146,381
17
$1.71M 1.11%
83,259
18
$1.68M 1.09%
56,359
19
$1.52M 0.99%
147,033
20
$775K 0.5%
260,000
21
$230K 0.15%
22,368
22
– –
-270,664
23
– –
-1,492,581
24
– –
-4,456
25
– –
-22,400
1
2